The GTPase-activating Protein GIT2 Protects Against Colitis by Negatively Regulating Toll-like Receptor Signaling

Juncheng Wei,Chao Wei,Min Wang,Xiao Qiu,Yang Li,Yanzhi Yuan,Chaozhi Jin,Ling Leng,Jian Wang,Xiaoming Yang,Fuchu He
DOI: https://doi.org/10.1073/pnas.1309218111
IF: 11.1
2014-01-01
Proceedings of the National Academy of Sciences
Abstract:Significance Inflammatory bowel disease is generally thought to develop from an abnormal immune response to the gut luminal microbiota in genetically predisposed individuals. Previous studies on G protein-coupled receptor kinase-interactor 2 (GIT2) have suggested that it regulates thymocyte positive selection, neutrophil-direction sensing, and cell motility during immune responses by regulating the activity of the small GTPases ADP ribosylation factors and Ras-related C3 botulinum toxin substrate 1. Here, we show that GIT2 protects against severe colitis in mice by inhibiting the ubiquitination of TNF receptor associated factor 6 and negatively regulating Toll-like receptor (TLR) signaling. GIT2 is essential for the resolution of TLR signaling, and the deficiency of Git2 leads to uncontrolled inflammation and severe immune diseases.
What problem does this paper attempt to address?